Management of Type 2 diabetes in Ramadan: Low-ratio premix insulin working group practical advice

  • Mohamed M. M.M. Hassanein
  • , Mohamed M. Belhadj
  • , Khalifa K. Abdallah
  • , Arpan Dev A.D. Bhattacharya
  • , Awadhesh Kumar A.K. Singh
  • , Khaled Abdullah K.A. Tayeb
  • , Monira M. M.M. Al-Arouj
  • , Awad A. Elghweiry
  • , Hinde H. Iraqi
  • , Mohamed M. Nazeer

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

The challenge of insulin use during Ramadan could be minimized, if people with diabetes are metabolically stable and are provided with structured education for at least 2-3 months pre-Ramadan. Although, American diabetes association (ADA) recommendations 2010 and South Asian Consensus Guideline 2012 deal with management of diabetes in Ramadan and changes in insulin dosage, no specific guidance on widely prescribed low-ratio premix insulin is currently available. Hence, the working group for insulin therapy in Ramadan, after collective analysis, evaluation, and opinion from clinical practice, have formulated a practical advice to empower physicians with pre-Ramadan preparation, dose adjustment, and treatment algorithm for self-titration of low-ratio premix insulin. © 2016 Elsevier B.V., All rights reserved.
Original languageAmerican English
Pages (from-to)794-799
Number of pages6
JournalIndian Journal of Endocrinology and Metabolism
Volume18
Issue number6
DOIs
StatePublished - 2014
Externally publishedYes

Funding Agency

  • Kuwait Foundation for the Advancement of Sciences

Fingerprint

Dive into the research topics of 'Management of Type 2 diabetes in Ramadan: Low-ratio premix insulin working group practical advice'. Together they form a unique fingerprint.

Cite this